Ang Li, MD, MS
@angli_md
Non-malignant hematologist. Epidemiology, health services, informatics researcher. #Thrombosis #Cancer #Microangiopathy. My views are my own
ID: 1224965920898134016
https://www.bcm.edu/research/faculty-labs/ang-li-lab 05-02-2020 08:00:14
40 Tweet
204 Followers
86 Following
Very excited to be presenting at #ISTH2023 on external validation of EHR risk score for cancer associated thrombosis Christopher Flowers See details: dynamicapp.shinyapps.io/EHR-CAT/ isthcongressdaily.org/articles/ArtMI…
How do changes in proposed study definition change research outcomes in rare hematologic diseases? doi.org/10.1016/j.jtct…. doi.org/10.1016/j.jtct…. @shenglingma Stephanie Lee, MD
Anticoagulation in #cancer-associated splanchnic vein #thrombosis (SpVT) requires judicious consideration for thrombotic & bleeding risk. This study by Shang et al. delves deeper into the natural history & management of SpVT. Ang Li, MD, MS jthjournal.org/article/S1538-… Elsevier Hematology
Should isolated splanchnic vein thrombosis be included in the outcome definition for "cancer associated thrombosis"? Our study shows that they are managed very differently. A multi-center study is needed! Marc Carrier Kristen Sanfilippo Rushad Patell authors.elsevier.com/a/1ielB5TuFxIt…
Not all #lymphomas are created equal. Different histology types pose unique #thrombosis risks. New #VTE risk assessment model in #lymphoma patients across 3 patient cohorts: doi.org/10.1002/ajh.27… Shengling Ma, MD, PhD
Similar survival outcomes can be achieved for aggressive large B-cell lymphoma in a safety-net hospital system with robust financial assistance program! R-IPI plus several other factors are prognostic Mark Jiang Christopher Flowers authors.elsevier.com/sd/article/S29…
Congratulations to Mohammad Saadatagah for presenting an oral abstract at #ASH24 annual meeting. He showed a mild association between #CHIP and #VTE in ARIC prospective cohort driven by TET2 BCM IM Residency BCM Department of Medicine
#ASH24 Dr. Sarah E Sartain presented our prospective cohort study of 101 pediatric patients undergoing allogeneic transplant Texas Children's. We found an 17% incidence of thrombotic microangiopathy (TMA) at 1-year & distinct longitudinal changes in sC5b9, Ba, ANG-1 & ANG-2 biomarkers!
Dr. Ang Li, MD, MS reported external validation of the EHR-CAT score (adaptions of the Khorana risk score) in 187 health care system (over 400,000 patients). Let’s implement this in EPIC to stratify patients according to their underlying risk of VTE! #ASH24
How important is #CHIP for #VTE risk in older adults with high prevalence? Find out in our newest publication JTH using #ARIC cohort by Mohammad Saadatagah Senthil Sukumar, MD Christie Ballantyne Mary Cushman 🫀🧠🩸 Statistically significant but clinically small effect! doi.org/10.1016/j.jtha…
